Cantitate/Preț
Produs

Alternative Splicing and Disease: Progress in Molecular and Subcellular Biology, cartea 44

Editat de Philippe Jeanteur
en Limba Engleză Hardback – 3 aug 2006
Splicing of primary RNA transcript, i.e. removal of introns and joining of exons to produce mature mRNAs competent for translation into proteins, is a quasi-systematic step of gene expression in higher organisms. However, this process is not unequivocal but can follow alternate pathways. Alternative splicing of a given transcript can therefore yield several distinct mRNAs encoding as many different proteins. Its full biological significance has not been appreciated until it was recognized that alternative splicing is so general as to affect about 75% of all human genes. Therefore, alternative splicing not only vastly increases protein diversity but also offers numerous opportunities for aberrant splicing events with pathological consequences.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 119517 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 30 noi 2010 119517 lei  6-8 săpt.
Hardback (1) 120105 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 3 aug 2006 120105 lei  6-8 săpt.

Din seria Progress in Molecular and Subcellular Biology

Preț: 120105 lei

Preț vechi: 146470 lei
-18% Nou

Puncte Express: 1802

Preț estimativ în valută:
22996 23946$ 19080£

Carte tipărită la comandă

Livrare economică 13-27 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783540344483
ISBN-10: 3540344489
Pagini: 257
Ilustrații: XII, 257 p. 26 illus., 2 illus. in color.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.56 kg
Ediția:2006
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Progress in Molecular and Subcellular Biology

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Methods and Platforms for the Quantification of Splice Variants' Expression.- Pre-mRNA Missplicing as a Cause of Human Disease.- Alternative Splicing: Therapeutic Target and Tool.- SR Proteins as Potential Targets for Therapy.- Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia.- Spinal Muscular Atrophy and Therapeutic Prospects.- Misregulation of Alternative Splicing Causes Pathogenesis in Myotonic Dystrophy.- Redirecting Splicing to Address Dystrophin Mutations: Molecular By-pass Surgery.- Altered Splicing in Prelamin A-Associated Premature Aging Phenotypes.- Splicing Modulation as a Modifier of the CFTR Function.

Textul de pe ultima copertă

Splicing of primary RNA transcript, i.e. removal of introns and joining of exons to produce mature mRNAs competent for translation into proteins, is a quasi-systematic step of gene expression in higher organisms. However, this process is not unequivocal but can follow alternate pathways. Alternative splicing of a given transcript can therefore yield several distinct mRNAs encoding as many different proteins. Its full biological significance has not been appreciated until it was recognized that alternative splicing is so general as to affect about 75% of all human genes. Therefore, alternative splicing not only vastly increases protein diversity but also offers numerous opportunities for aberrant splicing events with pathological consequences.

Caracteristici

First book to highlight the medical implications, i.e. diseases, caused by alternative splicing Outlines possible targets for therapy Written by internationally reknown experts Includes supplementary material: sn.pub/extras